Literature DB >> 19398702

Changes in MRS neuronal markers and T cell phenotypes observed during early HIV infection.

M R Lentz1, W K Kim, V Lee, S Bazner, E F Halpern, N Venna, K Williams, E S Rosenberg, R G González.   

Abstract

OBJECTIVE: To determine if changes in brain metabolites are observed during early HIV infection and correlate these changes with immunologic alterations.
METHODS: Eight subjects with early HIV infection, 9 HIV-seronegative controls, and 10 chronically HIV-infected subjects without neurologic impairment underwent 1H magnetic resonance spectroscopy. Subjects with early stage infection were identified near the time of HIV seroconversion and imaged within 60 days of an evolving Western blot, while still having detectable plasma virus. Subjects had blood drawn for viral RNA and T cell quantification.
RESULTS: Both N-acetylaspartate (NAA) and Glx (glutamate + glutamine) were decreased in the frontal cortical gray matter of seropositive subjects. NAA levels were found to be decreased in the centrum semiovale white matter of chronically HIV-infected subjects, but not in those with early infection. Both HIV-infected cohorts demonstrated a lower number of CD4+ T lymphocytes and a higher number of CD8+ T lymphocytes in their blood. Lower NAA levels in the frontal cortex of subjects with early infection were associated with an expansion of CD8+ T cells, especially effector CD8+ T cells.
CONCLUSIONS: These results verify metabolism changes occurring in the brain early during HIV infection. Lower NAA and Glx levels in the cortical gray matter suggests that HIV causes neuronal dysfunction soon after infection, which correlates to the expansion of CD8+ T cells, specifically to an activated phenotype. Utilizing magnetic resonance spectroscopy to track NAA levels may provide important information on brain metabolic health while allowing better understanding of the virus-host interactions involved in CNS functional deficits.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19398702      PMCID: PMC2677480          DOI: 10.1212/WNL.0b013e3181a2e90a

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  39 in total

1.  Immune control of HIV-1 after early treatment of acute infection.

Authors:  E S Rosenberg; M Altfeld; S H Poon; M N Phillips; B M Wilkes; R L Eldridge; G K Robbins; R T D'Aquila; P J Goulder; B D Walker
Journal:  Nature       Date:  2000-09-28       Impact factor: 49.962

2.  Highly activated CD8(+) T cells in the brain correlate with early central nervous system dysfunction in simian immunodeficiency virus infection.

Authors:  M C Marcondes; E M Burudi; S Huitron-Resendiz; M Sanchez-Alavez; D Watry; M Zandonatti; S J Henriksen; H S Fox
Journal:  J Immunol       Date:  2001-11-01       Impact factor: 5.422

3.  The central nervous system as a reservoir for simian immunodeficiency virus (SIV): steady-state levels of SIV DNA in brain from acute through asymptomatic infection.

Authors:  Janice E Clements; Tahar Babas; Joseph L Mankowski; K Suryanarayana; Michael Piatak; Patrick M Tarwater; Jeffrey D Lifson; M Christine Zink
Journal:  J Infect Dis       Date:  2002-09-13       Impact factor: 5.226

4.  Evidence of reduced glutamate in the frontal lobe of HIV-seropositive patients.

Authors:  Napapon Sailasuta; Kimberly Shriner; Brian Ross
Journal:  NMR Biomed       Date:  2009-04       Impact factor: 4.044

5.  A multi-center 1H MRS study of the AIDS dementia complex: validation and preliminary analysis.

Authors:  Patricia Lani Lee; Constantin T Yiannoutsos; Thomas Ernst; Linda Chang; Christina M Marra; Jeffrey G Jarvik; Todd L Richards; Edmund W Kwok; Dennis L Kolson; David Simpson; Cheuk Y Tang; Giovanni Schifitto; Leena M Ketonen; Dieter J Meyerhoff; Robert E Lenkinski; R Gilberto Gonzalez; Bradford A Navia
Journal:  J Magn Reson Imaging       Date:  2003-06       Impact factor: 4.813

6.  Altered neurometabolite development in HIV-infected children: correlation with neuropsychological tests.

Authors:  M A Keller; T N Venkatraman; A Thomas; A Deveikis; C LoPresti; J Hayes; N Berman; I Walot; S Padilla; J Johnston-Jones; T Ernst; L Chang
Journal:  Neurology       Date:  2004-05-25       Impact factor: 9.910

7.  Primary HIV type 1 infection.

Authors:  Sigall Kassutto; Eric S Rosenberg
Journal:  Clin Infect Dis       Date:  2004-04-30       Impact factor: 9.079

8.  HIV-1 specific CD8+ T cells with an effector phenotype and control of viral replication.

Authors:  Christoph Hess; Marcus Altfeld; Seddon Y Thomas; Marylyn M Addo; Eric S Rosenberg; Todd M Allen; Rika Draenert; Robert L Eldrige; Jan van Lunzen; Hans-J Stellbrink; Bruce D Walker; Andrew D Luster
Journal:  Lancet       Date:  2004-03-13       Impact factor: 79.321

9.  Perivascular macrophages are the primary cell type productively infected by simian immunodeficiency virus in the brains of macaques: implications for the neuropathogenesis of AIDS.

Authors:  K C Williams; S Corey; S V Westmoreland; D Pauley; H Knight; C deBakker; X Alvarez; A A Lackner
Journal:  J Exp Med       Date:  2001-04-16       Impact factor: 14.307

10.  A prospective longitudinal in vivo 1H MR spectroscopy study of the SIV/macaque model of neuroAIDS.

Authors:  Robert A Fuller; Susan V Westmoreland; Eva Ratai; Jane B Greco; John P Kim; Margaret R Lentz; Julian He; Prabhat K Sehgal; Eliezer Masliah; Elkan Halpern; Andrew A Lackner; R Gilberto González
Journal:  BMC Neurosci       Date:  2004-03-05       Impact factor: 3.288

View more
  61 in total

Review 1.  The role of medical imaging in defining CNS abnormalities associated with HIV-infection and opportunistic infections.

Authors:  David F Tate; Rola Khedraki; Daniel McCaffrey; Daniel Branson; Jeffrey Dewey
Journal:  Neurotherapeutics       Date:  2011-01       Impact factor: 7.620

2.  Increased subcortical neural activity among HIV+ individuals during a lexical retrieval task.

Authors:  April D Thames; Philip Sayegh; Kevin Terashima; Jessica M Foley; Andrew Cho; Alyssa Arentoft; Charles H Hinkin; Susan Y Bookheimer
Journal:  Neurobiol Dis       Date:  2015-10-17       Impact factor: 5.996

3.  Alterations in brain metabolism during the first year of HIV infection.

Authors:  Margaret R Lentz; Woong-Ki Kim; Hyun Kim; Caroline Soulas; Vallent Lee; Nagagopal Venna; Elkan F Halpern; Eric S Rosenberg; Kenneth Williams; R G González
Journal:  J Neurovirol       Date:  2011-04-15       Impact factor: 2.643

4.  A peripheral monocyte interferon phenotype in HIV infection correlates with a decrease in magnetic resonance spectroscopy metabolite concentrations.

Authors:  Lynn Pulliam; Hans Rempel; Bing Sun; Linda Abadjian; Cyrus Calosing; Dieter J Meyerhoff
Journal:  AIDS       Date:  2011-09-10       Impact factor: 4.177

5.  Quantitative MRI Measures in SIV-Infected Macaque Brains.

Authors:  Xiaodong Zhang; Chunxia Li
Journal:  J Clin Cell Immunol       Date:  2013

6.  HIV gp120 sequence variability associated with HAND in Hispanic Women.

Authors:  Krystal Colón; Fabián Vázquez-Santiago; Vanessa Rivera-Amill; Gisela Delgado; Steven E Massey; Valerie Wojna; Richard J Noel; Loyda M Meléndez
Journal:  J Virol Antivir Res       Date:  2015-10-06

7.  Regional cortical thinning associated with detectable levels of HIV DNA.

Authors:  Kalpana J Kallianpur; Gregory R Kirk; Napapon Sailasuta; Victor Valcour; Bruce Shiramizu; Beau K Nakamoto; Cecilia Shikuma
Journal:  Cereb Cortex       Date:  2011-10-19       Impact factor: 5.357

8.  Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline.

Authors:  Igor Grant; Donald R Franklin; Reena Deutsch; Steven P Woods; Florin Vaida; Ronald J Ellis; Scott L Letendre; Thomas D Marcotte; J H Atkinson; Ann C Collier; Christina M Marra; David B Clifford; Benjamin B Gelman; Justin C McArthur; Susan Morgello; David M Simpson; John A McCutchan; Ian Abramson; Anthony Gamst; Christine Fennema-Notestine; Davey M Smith; Robert K Heaton
Journal:  Neurology       Date:  2014-05-09       Impact factor: 9.910

9.  Substance use is a risk factor for neurocognitive deficits and neuropsychiatric distress in acute and early HIV infection.

Authors:  Erica Weber; Erin E Morgan; Jennifer E Iudicello; Kaitlin Blackstone; Igor Grant; Ronald J Ellis; Scott L Letendre; Susan Little; Sheldon Morris; Davey M Smith; David J Moore; Steven Paul Woods
Journal:  J Neurovirol       Date:  2012-12-19       Impact factor: 2.643

10.  Progressive cerebral injury in the setting of chronic HIV infection and antiretroviral therapy.

Authors:  Assawin Gongvatana; Jaroslaw Harezlak; Steven Buchthal; Eric Daar; Giovanni Schifitto; Thomas Campbell; Michael Taylor; Elyse Singer; Jeffrey Algers; Jianhui Zhong; Mark Brown; Deborah McMahon; Yuen T So; Deming Mi; Robert Heaton; Kevin Robertson; Constantin Yiannoutsos; Ronald A Cohen; Bradford Navia
Journal:  J Neurovirol       Date:  2013-04-24       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.